Health
Nanobody could be used as antiviral treatment against COVID-19 – Drug Target Review
Researchers have found a nanobody named Ty1 that neutralises SARS-CoV-2 by attaching itself to the Spike protein of COVID-19.
Posted: 4 September 2020 | Victoria Rees (Drug Target Review) | No comments yet
Researchers have found a nanobody named Ty1 that neutralises SARS-CoV-2 by attaching itself to the Spike protein of COVID-19.
Researchers have identified a small neutralising antibody, a so-called nanobody, that they say has the capacity to block SARS-CoV-2 from entering human cells. The researchers believe this nanobody has the potential to be developed as an antiviral treatment against COVID-19.
The study was c…
-
Noosa News21 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business24 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025
-
Noosa News22 hours agoE-biker charged with riding dangerously, assaulting cop
-
General20 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands